Table 2.
Author (year) | Study group |
Control group |
||||||
Incidence of renal failure | Incidence of hepatitis | Incidence of hypoxia | Incidence of leukopenia | Incidence of renal failure | Incidence of hepatitis | Incidence of hypoxia | Incidence of leukopenia | |
Perriëns et al. (1992) | 24/33(72.7%) | 13/33(39.4%) | 17/33(51.5%) | 0/33(0.0%) | 10/14(71.4%) | 5/14(35.7%) | 4/14(28.6%) | 0/14(0.0%) |
Lin et al. (1996) | 10/16(62.5%) | 3/16(18.8%) | 6/16(37.5%) | 10/17(58.8%) | 3/17(17.6%) | 0/17(0.0%) | ||
Lin et al. (1999) | 20/28(71.4%) | 5/28(17.9%) | 3/28(10.7%) | 8/28(28.5%) | 15/22(68.2%) | 6/22(27.3%) | 3/22(13.6%) | 0/22(0.0%) |
Lin et al. (2006) | 14/16(87.5%) | 4/16(25.0%) | 9/16(56.3%) | 6/16(37.4%) | 5/7(71.4%) | 1/7(14.5%) | 4/7(57.1%) | 0/7(0.0%) |
Afzali and Gholyaf (2008) | 6/9(66.6%) | 9/9(100.0%) | 4/9(44.2%) | 11/11(100.0%) | 11/11(100.0%) | 8/11(72.7%) | ||
Lin et al. (2011) | ||||||||
Ghorbani et al. (2015) | 11/24(45.8%) | 9/24(37.5%) | 10/24(41.6%) | 15/23(65.2%) | 11/23(47.8%) | 17/23(73.9%) |